Promoter pledge creation at Ajanta Pharma for NCD issuance (revised)

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.3%1-day move

₹3315.00

prior close

₹3262.00

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.1+0.2+0.1+0.1-0.3+1.5+3.3+3.1+4.1+2.9————

Up moveDown movePending

AI summary

Promoters of Ajanta Pharma, including Aayush Agrawal Trust, Aayush Agrawal individually, and Gabs Investments, have pledged 66.33 lakh shares (around 5.31 percent of capital) as security for non-convertible debenture issuance. NCDs are held by CTL Trusteeship for 360 ONE funds and 360 ONE Prime Ltd. This is a revised filing correcting the name of the entity holding the encumbrance. Post this, Aayush Agrawal Trust has 1.35 crore shares (10.83 percent) pledged, about 95.8 percent of its holding.

Likely market impact

Promoters raising debt via NCDs using shares as collateral. Aayush Trust is about 95 percent pledged, showing high leverage for that entity.